- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 413/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Patent holdings for IPC class C07D 413/14
Total number of patents in this class: 12224
10-year publication summary
|
720
|
745
|
874
|
889
|
887
|
903
|
1000
|
964
|
849
|
486
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4747 |
317 |
| Merck Sharp & Dohme LLC | 3737 |
236 |
| Boehringer Ingelheim International GmbH | 4487 |
230 |
| Novartis AG | 10224 |
225 |
| Gilead Sciences, Inc. | 2226 |
195 |
| F. Hoffmann-La Roche AG | 7816 |
186 |
| Takeda Pharmaceutical Company Limited | 2713 |
154 |
| Merck Patent GmbH | 5731 |
140 |
| Janssen Pharmaceutica N.V. | 3160 |
138 |
| Hoffmann-La Roche Inc. | 3804 |
133 |
| Amgen Inc. | 4431 |
122 |
| AstraZeneca AB | 2820 |
112 |
| Pfizer Inc. | 3400 |
111 |
| Vertex Pharmaceuticals Incorporated | 1579 |
89 |
| Genentech, Inc. | 4113 |
86 |
| Rigel Pharmaceuticals, Inc. | 505 |
84 |
| Syngenta Crop Protection AG | 6707 |
79 |
| LG Chem, Ltd. | 17937 |
76 |
| Bayer Pharma AG | 1009 |
68 |
| Bayer AG | 3504 |
62 |
| Other owners | 9381 |